EXCISION BIOTHERAPEUTICS INC

Profile

Company Names

EXCISION BIOTHERAPEUTICS INC

Addresses

988 MARKET STREET, SECOND FLOOR, SAN FRANCISCO, CA 94102

Phone Numbers

(404) 229-1162

 

Entity Type:

CORPORATION

Industry:

BIOTECHNOLOGY

Year Incorporated:

> 5 years ago

State Incorporated:

DELAWARE

Total Amount Raised:

$71,238,974.00

Number of Funding Rounds:

2
Investment Rounds
Round #
Round Open Date
Amount Raised
Total Round Size
Amount Remaining to be Raised
Securities
2
2021-02-16 
$10,500,000.00 
$10,500,000.00 
$0.00 
Equity, Debt 
1
2021-02-03 
$60,738,974.00 
$63,757,341.00 
$3,018,367.00 
Equity 
People
First Name
Middle Name
Last Name
Titles
Related Companies
VASUDEV 
 
BAILEY 
DIRECTOR
UNNATURAL PRODUCTS INC.   |  EXCISION BIOTHERAPEUTICS INC   |  OVERT BIO, INC.   |  OUTPACE BIO, INC.   |  HALCYON WELLNESS INC.
WILLIAM 
 
CARSON 
DIRECTOR
SCANBUY INC   |  HUDSON VENTURE PARTNERS III, L.P.   |  EXCISION BIOTHERAPEUTICS INC   |  TERRAPHASE ENGINEERING INC.
DANIEL 
 
DORNBUSCH 
EXECUTIVE OFFICER, DIRECTOR
EXCISION BIOTHERAPEUTICS INC
ASHOK 
 
KRISHNAMURTHI 
DIRECTOR
REFLEKTION, INC.   |  GREATPOINT VENTURES INNOVATION FUND, L.P.   |  GREATPOINT VENTURES INNOVATION PARALLEL FUND, L.P.   |  INSIGHT RX, INC.   |  COGNITIVE OPERATIONAL SYSTEMS, INC.   |  EVEN FINANCIAL, INC.   |  GREATPOINT VENTURES INNOVATION FUND II, L.P.   |  ACTIV SURGICAL, INC.   |  EXCISION BIOTHERAPEUTICS INC   |  GPV VIM ACQUISITION COMPANY, LLC   |  KLEARNOW CORP   |  LINUS BIOTECHNOLOGY INC.
Filings
Filing Date
Filing Type
Source URL
Industry Classifier
Detailed Industry
Revenue Range
Securities
First Sale Date
2021-03-03
D
Link
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Equity, Debt 
2021-02-16 
2021-02-22
D
Link
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Equity 
2021-02-03 
Brokers
Broker Dealer
Broker CRD#
Recipient Name
Recipient CRD#